Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of ...
A dual-action nanomaterial uses cancer’s own chemistry to destroy tumors while leaving healthy cells unharmed.
2don MSN
Dual-action molecule design concentrates cancer treatment in tumor cells to allow higher doses
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more ...
MedPage Today on MSN
Similar Prostate Cancer Drugs Show Different Results in Real-World Study
Better short-term survival with apalutamide versus darolutamide, but lots of unanswered qu ...
Scientists at the University of Virginia School of Medicine are chasing a new way to slow glioblastoma, the deadliest brain ...
Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...
A personalized cancer treatment developed by Moderna Inc. and Merck & Co. helped prevent the recurrence of high-risk skin cancer after five years, new data confirming its prolonged benefit show.
New research suggests cancer immunotherapy may work better when given earlier in the day. In a randomized lung cancer study, patients treated before 3 p.m. lived longer and had delayed cancer ...
Ongoing monitoring remains a cornerstone of survivorship care for patients with cancer, helping detect recurrence early and ...
My husband has been diagnosed with cancer. I know his treatment will be hard on him, and I want to help in any way with his ...
Breast cancer treatment costs thousands of dollars and often overwhelms patients with emotions when they receive their diagnosis.
EVERY great journey begins with a vision. For Tanzania’s Ocean Road Cancer Institute (ORCI), that vision was born out of compassion, necessity and bold determination to confront one of the world’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results